Correlation of polymorphisms of the vascular endothelial growth factor gene and the risk of lung cancer in an ethnic han group of North China

Experimental and Therapeutic Medicine

Volumn 3, Issue 4, 2012, Pages 673-676

  Li, Yan ^a   Liang, Jing ^a   Liu, Xiaolin ^a   Liu, Hairong ^a   Yin, Beibei ^a   Xiao, Junjuan ^a   Bi, Zhenqiang ^b  

^a THE FIRST AFFILIATED HOSPITAL OF SHANDONG FIRST MEDICAL UNIVERSITY   (China)

^b SHANDONG CENTER FOR DISEASE CONTROL AND PREVENTION   (China)

Author keywords

Genetic polymorphism; Lung cancer; Vascular endothelial growth factor gene

Indexed keywords

VASCULOTROPIN;

ALLELE; ARTICLE; CANCER RISK; CANCER SUSCEPTIBILITY; CHINA; CONTROLLED STUDY; ETHNICITY; GENE LOCUS; GENETIC ANALYSIS; GENETIC MARKER; GENETIC SUSCEPTIBILITY; GENOTYPE; HUMAN; LUNG CANCER; MAJOR CLINICAL STUDY; SINGLE NUCLEOTIDE POLYMORPHISM;

EID: 84863032493     PISSN: 17920981     EISSN: 17921015     Source Type: Journal    
DOI: 10.3892/etm.2012.453     Document Type: Article

References (17)

1. Shibuya M and Claesson-Welsh L: Signal transduction by VEGF receptors in regulation of angiogenesis and lymphangiogenesis. Exp Cell Res 312: 549-560, 2006.
2. Gotink KJ and Verheul HMW: Antiangiogenic tyrosine kinase inhibitors: What is their mechanism of action? Angiogenesis 13: 1-14, 2010.
3. O'Byrne KJ, Koukourakis MI, Giatromanolaki A, et al: Vascular endothelial growth factor, platelet-derived endothelial cell growth factor and angiogenesis in non-small cell cancer. Br J Cancer 82: 1427-1432, 2000.
4. Lee SJ, Lee SY, Jeon HS, et al: Vascular endothelial growth factor gene polymorphisms and risk of primary lung cancer. Cancer Epidemiol Biomarkers Prev 14: 571-575, 2005.
5. Baillie R, Harada K, Carlile J, Macluskey M, Schor SL and Schor AM: Expression of vascular endothelial growth factor in normal and tumor oral tissues with different antibodies. Histochem J 33: 287-294, 2001.
6. Salven P, Ruotsalainen T, Mattson K and Joensuu H: High pretreatment serum level of vascular endothelial growth factor (VEGF) is associated with poor outcome in small-cell lung cancer. Int J Cancer 79: 144-146, 2000.
7. Sheng H, Aoe M, Doihara H, Andou A and Shimizu N: Prognostic value of vascular endothelial growth factor expression in primary lung carcinoma. Acta Med Okayama 54: 119-126, 2000.
8. Yuan A, Yu CJ, Chen WJ, Lin FY, Kuo SH, Luh KT and Yang PC: Correlation of total VEGF mRNA and protein expression with histologic type, tumor angiogenesis, patient survival and timing of relapse in non-small cell lung cancer. Int J Cancer 89: 475-483, 2000.
9. Oshika Y, Nakamura M, Tokunaga T, et al: Expression of cell-associated isoform of vascular endothelial growth factor 189 and its prognostic relevance in non-small cell lung cancer. Int J Oncol 12: 541-544, 1998.
10. Collins FS, Patrinos A, Jordan E, Chakravarti A, Gesteland R and Walters L: New goals for the U.S. Human Genome Project: 1998-2003. Science 282: 682-689, 1998.
11. Wang DG, Fan JB, Siao CJ, et al: Large-scale identification, mapping, and genotyping of single-nucleotide polymorphisms in the human genome. Science 280: 1077-1082, 1998.
12. Roses AD: Pharmacogenetics and the practice of medicine. Nature 405: 857-865, 2000.
13. Kruglyak L and Nickerson DA: Variation is the spice of life. Nat Genet 27: 234-236, 2001.
14. Przeworski M, Hudson RR and di Rienzo A: Adjusting the focus on human variation. Trends Genet 16: 296-302, 2000.
15. Jacobs EJ, Feigelson HS, Bain EB, et al: Polymorphisms in the vascular endothelial growth factor gene and breast cancer in the Cancer Prevention Study II cohort. Breast Cancer Res 8: 22, 2006.
16. Jin Q, Hemminki K, Enquist K, et al: Vascular endothelial growth factor polymorphisms in relation to breast cancer development and prognosis. Clin Cancer Res 11: 3647-3653, 2005.
17. Renner W, Kotschan S, Hoffmann C, Obermayer-Pietsch B and Pilger E: A common 936 C/T mutation in the gene for vascular endothelial growth factor is associated with vascular endothelial growth factor plasma levels. J Vasc Res 37: 443-448, 2000.